Published in Dig Liver Dis on September 01, 2003
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ (2010) 4.69
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut (2005) 3.31
A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol (2015) 2.35
Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut (2007) 1.90
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol (2008) 1.19
Utility of faecal calprotectin analysis in adult inflammatory bowel disease. World J Gastroenterol (2012) 1.12
Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Dig Liver Dis (2003) 1.10
Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes. BMC Res Notes (2009) 1.01
Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease. Dig Dis Sci (2011) 0.97
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol (2014) 0.93
Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study. PLoS One (2014) 0.92
Stability of the maternal gut microbiota during late pregnancy and early lactation. Curr Microbiol (2013) 0.91
Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis (2008) 0.90
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study. Glob Adv Health Med (2014) 0.89
Carrageenan-induced colonic inflammation is reduced in Bcl10 null mice and increased in IL-10-deficient mice. Mediators Inflamm (2013) 0.88
Frequency of abnormal fecal biomarkers in irritable bowel syndrome. Glob Adv Health Med (2014) 0.88
The role and utility of faecal markers in inflammatory bowel disease. Therap Adv Gastroenterol (2015) 0.87
Novel serum and urine markers for pediatric appendicitis. Acad Emerg Med (2012) 0.87
Update of faecal markers of inflammation in children with cystic fibrosis. Mediators Inflamm (2012) 0.87
Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn's Disease Using Biomarkers, Capsule Endoscopy, and Imaging. Am J Gastroenterol (2015) 0.87
Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease. Can J Gastroenterol Hepatol (2015) 0.87
Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis. J Rheumatol (2011) 0.86
Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol (2010) 0.86
Improving the Preoperative Diagnostic Accuracy of Acute Appendicitis. Can Fecal Calprotectin Be Helpful? PLoS One (2016) 0.84
Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease. Frontline Gastroenterol (2010) 0.84
Effects of chitosan on intestinal inflammation in weaned pigs challenged by enterotoxigenic Escherichia coli. PLoS One (2014) 0.83
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol (2014) 0.82
How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol (2016) 0.81
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis. EBioMedicine (2015) 0.81
Disease monitoring in inflammatory bowel disease. World J Gastroenterol (2015) 0.80
Calprotectin as a diagnostic tool for inflammatory bowel diseases. Biomed Rep (2016) 0.79
Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum". Int J Inflam (2012) 0.79
Inflammatory responses in the muscle coat of stomach and small bowel in the postoperative ileus model of guinea pig. Yonsei Med J (2013) 0.79
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. J Gastroenterol (2016) 0.79
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? World J Gastroenterol (2007) 0.78
Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease. Therap Adv Gastroenterol (2016) 0.77
Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists. Dig Dis Sci (2014) 0.77
Fecal biomarkers of intestinal health and disease in children. Front Pediatr (2014) 0.77
Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome. Adv Biomed Res (2015) 0.76
Effect of age, gestation and lactation on faecal IgA and calprotectin concentrations in dogs. J Nutr Sci (2014) 0.76
Dientamoeba fragilis, One of the Neglected Intestinal Protozoa. J Clin Microbiol (2016) 0.76
Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain. Gastroenterol Res Pract (2016) 0.75
Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in Poland. Prz Gastroenterol (2014) 0.75
Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Sci Rep (2016) 0.75
Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome. Frontline Gastroenterol (2016) 0.75
Assessment of disease activity by fecal immunochemical test in ulcerative colitis. World J Gastroenterol (2016) 0.75
Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease. Intest Res (2016) 0.75
Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn's disease. Prz Gastroenterol (2015) 0.75
Homeostasis of the Gut Barrier and Potential Biomarkers. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Exposure to common food additive carrageenan alone leads to fasting hyperglycemia and in combination with high fat diet exacerbates glucose intolerance and hyperlipidemia without effect on weight. J Diabetes Res (2015) 0.75
Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease. BMC Gastroenterol (2016) 0.75
Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice. Front Med (Lausanne) (2017) 0.75
Biomarkers and non-invasive tests for gastrointestinal mucositis. Support Care Cancer (2017) 0.75
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut (2005) 3.31
Assembly of the nuclear transcription and processing machinery: Cajal bodies (coiled bodies) and transcriptosomes. Mol Biol Cell (1999) 2.80
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27
Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci (1999) 2.27
Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology (2000) 1.68
Intrahepatic metastatic nodules of hepatocellular carcinoma detected at lipiodol-CT: imaging-pathologic correlation. Abdom Imaging (1997) 1.63
The general practitioner's approach to irritable bowel syndrome: from intention to practice. Dig Liver Dis (2005) 1.62
Double pylorus: report of two cases and review of the literature. Ital J Gastroenterol (1992) 1.60
hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res (1993) 1.58
Spectroscopic characterization of mineralogy and its diversity across Vesta. Science (2012) 1.57
Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease. Alcohol Alcohol (1997) 1.46
Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology (1995) 1.43
VREPAR projects: the use of virtual environments in psycho-neuro-physiological assessment and rehabilitation. Cyberpsychol Behav (1999) 1.41
Transverse loop colostomy and colonic motility. Tech Coloproctol (2014) 1.40
Asymptomatic live systemic embolization observed on transesophageal echocardiography. Am Heart J (1993) 1.39
Coronary vasospasm in angina pectoris. Lancet (1977) 1.31
High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatment. J Infect Dis (1999) 1.25
Distinctive space weathering on Vesta from regolith mixing processes. Nature (2012) 1.23
Vesta's shape and morphology. Science (2012) 1.23
Pitted terrain on Vesta and implications for the presence of volatiles. Science (2012) 1.20
Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ (2013) 1.19
TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol (2001) 1.16
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol (1997) 1.11
Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol (1997) 1.08
The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern. Ital J Gastroenterol Hepatol (1997) 1.07
Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol (2001) 1.06
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer (1995) 1.05
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol (2014) 1.02
Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy. J Pharm Biomed Anal (1998) 1.00
TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology. J Med Virol (2001) 1.00
Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System. Science (2011) 0.99
Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: a case-control study. Eye (Lond) (2007) 0.99
High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. J Chromatogr (1988) 0.98
Phase-locked white-light continuum pulses: toward a universal optical frequency-comb synthesizer. Opt Lett (2000) 0.96
The role of antibodies and serum complement in the interaction between macrophages and leptospires. J Gen Microbiol (1982) 0.95
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil (2013) 0.94
Adaptive detection of arbitrarily shaped ultrashort quantum light states. Phys Rev Lett (2012) 0.94
Wegener's granulomatosis arising in pregnancy. J Laryngol Otol (1986) 0.92
Distribution of propafenone and its active metabolite, 5-hydroxypropafenone, in human tissues. Am Heart J (1987) 0.90
Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med (1994) 0.88
Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol (1999) 0.87
Helicobacter pylori stool antigen test: clinical evaluation and cost analysis of a new enzyme immunoassay. Dig Dis Sci (1999) 0.87
Psychiatric distress and health-related quality of life in obesity. Diabetes Nutr Metab (2003) 0.87
Cardiac tamponade as first manifestation of acute lymphoblastic leukemia in a patient with echographic evidence of mediastinal lymph nodal enlargement. Am Heart J (1985) 0.87
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother (1998) 0.87
Perfluorocarbon liquid assisted large retinal epithelium patching in sub-macular hemorrhage secondary to age related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2008) 0.87
Obsessional scores and subjective general psychiatric complaints of patients with duodenal ulcer or ulcerative colitis. Psychol Med (1976) 0.86
[Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine]. G Ital Cardiol (1985) 0.85
Experimental demonstration of the bosonic commutation relation via superpositions of quantum operations on thermal light fields. Phys Rev Lett (2009) 0.85
Mathematical skills in Prader-Willi Syndrome. J Intellect Disabil Res (2005) 0.84
Bright carbonate deposits as evidence of aqueous alteration on (1) Ceres. Nature (2016) 0.84
Olivine in an unexpected location on Vesta's surface. Nature (2013) 0.84
Neurotrophic keratitis. Ophthalmologica (2013) 0.83
Noun verb dissociation in Parkinson's disease. Brain Cogn (2002) 0.82
Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans. Clin Pharmacol Ther (1987) 0.82
Polypoidal choroidal vasculopathy: recent advances in therapy. Curr Drug Targets (2011) 0.82
Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method. J Virol Methods (1999) 0.82
Evaluation of a commercial serological kit for detection of salivary immunoglobulin G to Helicobacter pylori: a multicentre study. Eur J Gastroenterol Hepatol (2000) 0.82
Two-photon Fourier spectroscopy with femtosecond light pulses. Opt Lett (1997) 0.81
Nonalcoholic steatohepatitis and the "bright liver syndrome": should a recently expanded clinical entity be further expanded? Am J Gastroenterol (1995) 0.81
Repeated pseudoendophthalmitis after combined photodynamic therapy and intravitreal triamcinolone. Graefes Arch Clin Exp Ophthalmol (2007) 0.81
Post-traumatic inflammatory pseudotumor of the esophagus. Gastrointest Endosc (2001) 0.81
[Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture]. Arch Soc Esp Oftalmol (2011) 0.81
T-cell tumour necrosis factor-alpha receptor binding in demented patients. J Neurol (1997) 0.80
Extreme ultraviolet interferometry measurements with high-order harmonics. Opt Lett (2000) 0.80
Identification of an amphibian oocyte nuclear protein as a candidate for a role in embryonic DNA replication. Int J Dev Biol (1993) 0.80
Antibodies to citrullinated peptides in tuberculosis. Clin Rheumatol (2013) 0.80
Scheme for proving the bosonic commutation relation using single-photon interference. Phys Rev Lett (2008) 0.80
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori. Dig Liver Dis (2002) 0.79
Relative stability of meningococcal serogroup A and X polysaccharides. Vaccine (2012) 0.79
Lampbrush W and Z heterochromosome characterization with a monoclonal antibody and heat-induced chromosomal markers in the newt Pleurodeles waltl: W chromosome plays a role in female sex determination. Chromosoma (1990) 0.79
Histopathological findings in an epimacular membrane after intraoperative use of perfluorocarbon liquid. Eye (Lond) (2009) 0.79
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year. Aliment Pharmacol Ther (2011) 0.79
Binge eating disorder in obesity: comparison of different therapeutic strategies. Eat Weight Disord (2005) 0.79
Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders. Clin Immunol Immunopathol (1998) 0.79
TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy. Mediators Inflamm (2013) 0.79
The ejection of triatomic molecular hydrogen ions H(3) (+) produced by the interaction of benzene molecules with ultrafast laser pulses. J Chem Phys (2009) 0.78
Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines. Vaccine (2013) 0.78
Cognitive behavioural therapy for obesity: one-year follow-up in a clinical setting. Eat Weight Disord (2003) 0.78
Diagnostic accuracy of CT colonography in patients with positive faecal occult blood test: results of the Italian project Legatumori 2003-2006. Radiol Med (2009) 0.78
Role of inflammation in endophthalmitis. Mediators Inflamm (2012) 0.78
Management of chronic constipation in general practice. Tech Coloproctol (2013) 0.78